[Cotard syndrome].
Mori
Takaaki
T
Department of Neuropsychiatry, Ehime University School of Medicine.
Ikeda
Manabu
M
Tanabe
Hirotaka
H
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001927:Brain Diseases / Q000150:complications; D003702:Delusions / Q000175:diagnosis / Q000209:etiology / Q000523:psychology / Q000628:therapy; D003717:Denial, Psychological; D003866:Depressive Disorder / Q000175:diagnosis / Q000209:etiology / Q000523:psychology / Q000628:therapy; D004565:Electroconvulsive Therapy; D006801:Humans; D010259:Paranoid Disorders / Q000150:complications; D012015:Reference Standards; D013577:Syndrome
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents